CTSL and breast cancer: Making use of a newly established mouse line that enables the conditional genetic ablation of Ctsl in the transgenic MMTV-PyMT breast cancer model, we report that Ctsl-deficiency in mammary epithelial tumor cells resulted in a considerable delay in the emergence of tumors.